The provision will enable whole genome sequencing for neonatal and paediatric patients in intensive care units within 48 ...

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx ...

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...

GAITHERSBURG, Md. - GeneDx (NASDAQ:WGS), a genomic insights company with a market capitalization of $1.95 billion, announced the introduction of its ultraRapid Whole Genome Sequencing service, which ...

GeneDx has a big market in mind for its genetic testing: every newborn baby. The 24-year-old-company wants to make the ...

Integration streamlines the implementation process and enhances the clarity and accessibility of results within the EHR, UNC ...

A little-known stock started to make a huge name for itself in 2024. That stock is GeneDX WGS. Through the course of 2024, this healthcare company increased its market capitalization from under $ ...

A little-known stock started to make a huge name for itself in 2024. That stock is GeneDX (NASDAQ: WGS). Through the course of 2024, this healthcare company increased its market capitalization from ...

If you want to know who really controls GeneDx Holdings Corp. (NASDAQ:WGS), then you'll have to look at the makeup of its share registry. The group holding the most number of shares in the company ...